HOME >> BIOLOGY >> NEWS
Herpes tool allows researchers to customize Alzheimer's vaccine

Scientists have taken an important step toward creating a vaccine against Alzheimer's disease, customizing the response of the immune system with unprecedented precision.

Using a harmless form of the herpes virus, scientists at the University of Rochester Medical Center put into mice a payload of genetic information that created a carefully crafted immune response, one that muted the type of toxic side effects seen in a previous study in people of a vaccine against Alzheimer's. The work was published on-line June 25 in Neurobiology of Aging.

Though the current study was not in people but in mice, researchers are excited because it demonstrates a level of control over an Alzheimer's vaccine that was previously unattainable.

"This work provides a platform to shuffle the immune response, a flexibility to modify the approach to create a vaccine that is safe and efficacious," says Howard Federoff, M.D., Ph.D., professor of neurology and director of the Center for Aging and Developmental Biology. "This points the way toward shaping and modulating the exact immune response needed to fight or prevent Alzheimer's disease."

In a previous study, other researchers showed that a potential vaccine designed to protect against Alzheimer's was apparently effective in some people but the vaccine caused severe inflammation in the brains of several participants, and the study was halted last year because of the danger.

With funding from the National Institutes of Health, Federoff and William Bowers, Ph.D., assistant professor of Neurology, set out to create a vaccine without the harmful side effects, by boosting part of the immune system not responsible for the side effects. And they succeeded: While a vaccine most like the previous form proved lethal to four out of six mice, a modified form of the vaccine, additionally equipped with a tetanus toxin to alter the immune response, proved much safer while still causing a 20-percent decline in
'"/>

Contact: Tom Rickey
trickey@admin.rochester.edu
585-275-7954
University of Rochester Medical Center
29-Jun-2004


Page: 1 2 3

Related biology news :

1. Herpes research uncovers possible clue to Alzheimers disease
2. Herpes virus trashes detection mechanism to hide from immune system
3. Cheap, Soy-Based Antibodies Prevent Genital Herpes In Mice
4. Social Stress Causes Dormant Herpes Virus To Resurface In Mice
5. Common Anti-Viral Medication Prevents Severe Eye Herpes
6. New Herpesvirus Receptor Discovered That Allows Entry of Both Herpes Simplex-1And -2 And Animal Herpesviruses Into Human Cells
7. Herpes Virus Strain Identified As A Trigger In Multiple Sclerosis
8. Herpes-Based Gene Therapy Is Key To Promising Liver Tumor Vaccine
9. Herpes-Based Gene Therapy Is Key To Promising Liver Tumor Vaccine
10. Northwestern Scientists Discover How Herpes Simplex Virus Infects Cells
11. Whole body imaging allows better understanding of the immune system

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: